EAGLE PHARMACEUTICALS, INC. Quarterly Net Cash Provided by (Used in) Investing Activities in USD from Q4 2013 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
Summary
Eagle Pharmaceuticals, Inc. quarterly/annual Net Cash Provided by (Used in) Investing Activities history and growth rate from Q4 2013 to Q1 2023.
  • Eagle Pharmaceuticals, Inc. Net Cash Provided by (Used in) Investing Activities for the quarter ending March 31, 2023 was -$12.6M, a 7375% decline year-over-year.
  • Eagle Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2022 was -$86.8M, a 1531% decline from 2021.
  • Eagle Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2021 was -$5.32M, a 70.8% increase from 2020.
  • Eagle Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2020 was -$18.2M, a 2248% decline from 2019.
Net Cash Provided by (Used in) Investing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Investing Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 -$12.6M -$12.4M -7375% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-09
Q1 2022 -$168K +$5.22M +96.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q1 2021 -$5.38M +$12.6M +70% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q1 2020 -$18M -$17.8M -10054% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q1 2019 -$177K -$158K -832% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q1 2018 -$19K +$657K +97.2% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
Q1 2017 -$676K +$3.23M +82.7% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q1 2016 -$3.9M +$12.1M +75.7% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-08
Q1 2015 -$16M -$16M -57189% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 $20M +$20M Oct 1, 2014 Dec 31, 2014 10-K 2017-03-15
Q1 2014 -$28K Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-15
Q4 2013 -$7K* Oct 1, 2013 Dec 31, 2013 10-QT 2015-02-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.